KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Inventory: 2009-2024

Historic Change in Inventory for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Dec 2024 value amounting to $45.5 million.

  • Jazz Pharmaceuticals' Change in Inventory rose 243.62% to $31.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.4 million, marking a year-over-year increase of 297.53%. This contributed to the annual value of $45.5 million for FY2024, which is 239.36% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Change in Inventory of $45.5 million as of FY2024, which was up 239.36% from $13.4 million recorded in FY2023.
  • In the past 5 years, Jazz Pharmaceuticals' Change in Inventory registered a high of $49.6 million during FY2022, and its lowest value of $13.4 million during FY2023.
  • Moreover, its 3-year median value for Change in Inventory was $45.5 million (2024), whereas its average is $36.2 million.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Change in Inventory crashed by 72.97% in 2023 and then skyrocketed by 239.36% in 2024.
  • Jazz Pharmaceuticals' Change in Inventory (Yearly) stood at $30.5 million in 2020, then surged by 60.01% to $48.9 million in 2021, then climbed by 1.60% to $49.6 million in 2022, then crashed by 72.97% to $13.4 million in 2023, then spiked by 239.36% to $45.5 million in 2024.